Antonio Lanzavecchia
Corporate Officer/Principal presso VIR BIOTECHNOLOGY, INC.
Profilo
Antonio Lanzavecchia is the founder of Humabs BioMed SA. He currently holds multiple positions including Director at Adienne SA, Professor at Università della Svizzera Italiana, Swiss Federal Institute of Technology, and the University of Genoa, Member of the National Academy of Sciences, European Molecular Biology Organization, and Swiss Academy of Medical Sciences, and Senior Vice President at Vir Biotechnology, Inc. Previously, he was a Member at Basel Institute for Immunology from 1983 to 1999.
He received his undergraduate degree from the University of Pavia.
Posizioni attive di Antonio Lanzavecchia
Società | Posizione | Inizio |
---|---|---|
VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - |
Adienne SA
Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland. | Director/Board Member | - |
Institute For Research In Biomedicine
Institute For Research In Biomedicine BiotechnologyHealth Technology The Institute for Research in Biomedicine provides research and development services in the field of biomedicine. | Director/Board Member | 01/01/2000 |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Founder | 01/08/2011 |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Università della Svizzera Italiana | Corporate Officer/Principal | - |
University of Genoa | Corporate Officer/Principal | - |
Swiss Federal Institute of Technology | Corporate Officer/Principal | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
░░░░░ ░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Precedenti posizioni note di Antonio Lanzavecchia
Società | Posizione | Fine |
---|---|---|
░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Antonio Lanzavecchia
University of Pavia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VIR BIOTECHNOLOGY, INC. | Health Technology |
Aziende private | 6 |
---|---|
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
European Molecular Biology Organization | |
Swiss Academy of Medical Sciences | |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Commercial Services |
Adienne SA
Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland. | Health Technology |
Institute For Research In Biomedicine
Institute For Research In Biomedicine BiotechnologyHealth Technology The Institute for Research in Biomedicine provides research and development services in the field of biomedicine. | Health Technology |
- Borsa valori
- Insiders
- Antonio Lanzavecchia